Agilent Technologies (Santa Clara, California) and the University of Technology Sydney (UTS, Sydney, Australia) have established the UTS Elemental Bio-Imaging Facility to study trace metals and other elements in tissue and their effects on health.
Agilent Technologies (Santa Clara, California) and the University of Technology Sydney (UTS, Sydney, Australia) have established the UTS Elemental Bio-Imaging Facility to study trace metals and other elements in tissue and their effects on health. The facility opened on June 27. Agilent is providing an ICP–MS system, an LC–MS system, funding for project work, scholarships for graduate students for research in bioimaging, technical consulting, and a grant to develop imaging technology.
New TRC Facility Accelerates Innovation and Delivery
April 25th 2025We’ve expanded our capabilities with a state-of-the-art, 200,000 sq ft TRC facility in Toronto, completed in 2024 and staffed by over 100 PhD- and MSc-level scientists. This investment enables the development of more innovative compounds, a broader catalogue and custom offering, and streamlined operations for faster delivery. • Our extensive range of over 100,000 high-quality research chemicals—including APIs, metabolites, and impurities in both native and stable isotope-labelled forms—provides essential tools for uncovering molecular disease mechanisms and exploring new opportunities for therapeutic intervention.
New Guide: Characterising Impurity Standards – What Defines “Good Enough?”
April 25th 2025Impurity reference standards (IRSs) are essential for accurately identifying and quantifying impurities in pharmaceutical development and manufacturing. Yet, with limited regulatory guidance on how much characterisation is truly required for different applications, selecting the right standard can be challenging. To help, LGC has developed a new interactive multimedia guide, packed with expert insights to support your decision-making and give you greater confidence when choosing the right IRS for your specific needs.